MELANIE DE GUZMAN: Open Payments
NPI 1699128736 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 22 payments from 15 companies in 2025. Trend: 2023 $731 · 2024 $400 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 3 | $67 |
| Eisai Inc. | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Amgen Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
Products named: DAYBUE, Leqembi, LEQVIO, TRELEGY ELLIPTA, JARDIANCE, AIRSUPRA, Korlym, Wegovy.
Industry payments across FL — which companies pay providers there.
